Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1995-06-01
1997-01-14
Higel, Floyd D.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514397, 514398, 514399, 546121, 5483061, 5483064, A61K 3144, C07D47102
Patent
active
055940030
ABSTRACT:
Angiotensin-II antagonists of the formula ##STR1## wherein R.sub.1 is, other than hydrogen and, inter alia, halogen, lower alkyl or cycloalkyl; R.sub.2 is, inter alia, optionally substituted benzimidazol-2-yl, 5,6,7,8-tetrahydro-imidazo[1,2-a]pyridin-2-yl, butanesultam-1-yl, imidazol-4-yl, and tetrahydobenzimidazol-2-yl; R.sub.3 is, inter alia, lower alkyl; and, R.sub.4 is an acidic group, such as carboxyl or tetrazolyl. An compound is:
REFERENCES:
patent: 3929814 (1975-12-01), Narayanan et al.
patent: 4492708 (1985-01-01), Spitzer
patent: 5171748 (1992-12-01), Roberts et al.
patent: 5189048 (1993-02-01), Carini et al.
patent: 5190942 (1993-03-01), Poss
patent: 5194435 (1993-03-01), Kees
patent: 5200422 (1993-04-01), Olesen et al.
patent: 5218125 (1993-06-01), Chen et al.
patent: 5250554 (1993-10-01), Naka et al.
patent: 5254546 (1993-10-01), Ardecky et al.
Entzeroth Michael
Hauel Norbert
Narr, deceased Berthold
Ries Uwe
van Meel Jacobus C. A.
Dr. Karl Thomae GmbH
Higel Floyd D.
Raymond Robert P.
Rieder Wendy E.
Stempel Alan R.
LandOfFree
Tetrahydroimidazo[1,2-a]pyridin-2-yl-(benzimidazol-1-yl)-methyl- does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Tetrahydroimidazo[1,2-a]pyridin-2-yl-(benzimidazol-1-yl)-methyl-, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Tetrahydroimidazo[1,2-a]pyridin-2-yl-(benzimidazol-1-yl)-methyl- will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1388463